Evidence map›Paper›PMID 23306439›Full record

ArticleScience (New York, N.Y.)2013

Rif1 prevents resection of DNA breaks and promotes immunoglobulin class switching.

Michela Di Virgilio, Elsa Callen, Arito Yamane, Wenzhu Zhang, Mila Jankovic, Alexander D Gitlin, Niklas Feldhahn, Wolfgang Resch, Thiago Y Oliveira, Brian T Chait and 4 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 276 papers.

0numbers the graph read from it
0cells of the map it votes in
276citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

276 citing papers in PubMed.

  1. Mechanisms and disease relevance of DNA break repair pathway choice.Nature reviews. Molecular cell biology · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

216 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Michela Di VirgilioLaboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.
Elsa Callen
Arito Yamane
Wenzhu Zhang
Mila Jankovic
Alexander D Gitlin
Niklas Feldhahn
Wolfgang Resch
Thiago Y Oliveira
Brian T Chait
André Nussenzweig
Rafael Casellas
Davide F Robbiani
Michel C Nussenzweig

Funding

Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
RAG and AID biologyZIAAR041148 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI O'SHEA, JOHN · 2009 to 2025
$44.8M
Relationship between DNA damage detection and signalingZIABC010959 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSENZWEIG, ANDRE A. · 2009 to 2025
$27.0M
DNA RepairZIABC010283 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSENZWEIG, ANDRE A. · 2009 to 2025
$27.0M
NEW TOOLS FOR EXPLORING THE DYNAMIC INTERACTOME(RMI)U54RR022220 · NCRR · ROCKEFELLER UNIVERSITY · PI ROUT, MICHAEL P · 2005 to 2011
$19.3M
YNG1 PHD BINDING TO H3 3METHYL AT K4 PROMOTES TRANSCRIPTION AT TARGETED ORFSP41RR000862 · NCRR · ROCKEFELLER UNIVERSITY · PI DARNELL, JAMES E · 1985 to 2011
$16.1M
National Resource for Mass Spectrom of Biological MacromoleculesP41GM103314 · NIGMS · ROCKEFELLER UNIVERSITY · PI CHAIT, BRIAN T · 2012 to 2017
$9.9M
Class Switch Recombination in B LymphocytesR37AI037526 · NIAID · ROCKEFELLER UNIVERSITY · PI NUSSENZWEIG, MICHEL C · 2014 to 2023
$5.4M
SIGNALLING PATHWAYS IN AUTOIMMUNITYR01AI037526 · NIAID · ROCKEFELLER UNIVERSITY · PI NUSSENZWEIG, MICHEL C · 1994 to 2012
$5.0M
Howard Hughes Medical InstituteIntramural NIH HHSNCRR NIH HHS P41 RR000862NCRR NIH HHS RR00862NCRR NIH HHS RR022220NCRR NIH HHS U54 RR022220NIAID NIH HHS AI037526NIAID NIH HHS R01 AI037526NIAID NIH HHS R37 AI037526NIGMS NIH HHS GM007739NIGMS NIH HHS GM103314NIGMS NIH HHS P41 GM103314NIGMS NIH HHS T32 GM007739
6 · The paper itself

Abstract

DNA double-strand breaks (DSBs) represent a threat to the genome because they can lead to the loss of genetic information and chromosome rearrangements. The DNA repair protein p53 binding protein 1 (53BP1) protects the genome by limiting nucleolytic processing of DSBs by a mechanism that requires its phosphorylation, but whether 53BP1 does so directly is not known. Here, we identify Rap1-interacting factor 1 (Rif1) as an ATM (ataxia-telangiectasia mutated) phosphorylation-dependent interactor of 53BP1 and show that absence of Rif1 results in 5'-3' DNA-end resection in mice. Consistent with enhanced DNA resection, Rif1 deficiency impairs DNA repair in the G(1) and S phases of the cell cycle, interferes with class switch recombination in B lymphocytes, and leads to accumulation of chromosome DSBs.

Indexed as

DNA Breaks, Double-StrandedImmunoglobulin Class SwitchingAnimalsAtaxia Telangiectasia Mutated ProteinsB-LymphocytesCell Cycle ProteinsCells, CulturedChromosomal Proteins, Non-HistoneDNADNA-Binding ProteinsDNA RepairG1 PhaseG2 PhaseGenomic InstabilityMicePhosphorylationAtaxia Telangiectasia Mutated ProteinsAtm protein, mouseCell Cycle ProteinsChromosomal Proteins, Non-HistoneDNADNA-Binding ProteinsProtein Serine-Threonine KinasesRif1 protein, mouseTelomere-Binding ProteinsTrp53bp1 protein, mouseTumor Suppressor p53-Binding Protein 1Tumor Suppressor Proteins

Identifiers

PMID23306439
PMCPMC3815530

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.